Female cystic fibrosis mutation carriers and assisted reproductive technology: Does carrier status affect reproductive outcomes?

Teresa A. VanWort, Joseph A. Lee, Hrishikesh Karvir, Michael C. Whitehouse, Piraye Yurttas Beim, Alan B. Copperman

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


Objective: To evaluate the association between female cystic fibrosis (CF) carrier status and invitro fertilization (IVF) response and outcomes. The presence of cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations inmale carriers has been associated with infertility, yet possible adverse effects on the ovarian function and reproductive outcomes of female carriers have not been studied to date. Design: Retrospective cohort study. Setting: Private academic, clinical reproductive center. Patient(s): Females <40 years of age who were screened for CFTR mutations and received IVF treatment between July 2002 and March 2013. Intervention(s): Patients initiated controlled ovarian hyperstimulation with frequent monitoring, vaginal oocyte retrieval, fertilization, embryo transfer, and a pregnancy test. Various measures of IVF stimulation response and cycle outcome were evaluated for both carriers and noncarriers. Main Outcome Measure(s): Analysis was performed by logistic regression and Poisson regression. Result(s): IVF cycles (n = 199) from CFTR mutation carrier patients (n = 112) were analyzed. No signi ficant differences in outcome were noted when carriers of different mutation loci were compared in aggregate with the noncarrier group (n = 6,420 cycles from 3,555 patients). Signifi cant differences were noted for some metrics when the carriers were grouped by mutation loci. Conclusion(s): Overall, no signi ficant differences in stimulation response and cycle outcome were noted between female CFTR mutation carriers and noncarriers. Further research is needed to investigate whether the differences noted between specific CFTR mutation loci are clinically relevant and whether CFTR mutations may impact reproductive outcomes outside the context of assisted reproductive technologies.

Original languageEnglish
Pages (from-to)1324-1330
Number of pages7
JournalFertility and Sterility
Issue number5
StatePublished - 2014


  • Cystic fibrosis
  • Female fertility
  • Heterozygote
  • In vitro fertilization
  • Ovarian function


Dive into the research topics of 'Female cystic fibrosis mutation carriers and assisted reproductive technology: Does carrier status affect reproductive outcomes?'. Together they form a unique fingerprint.

Cite this